CLINICAL_TRIALS
trial_result
· 2015-10-07
Clinical Trial Update: Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea [Phase 1]
Summary
Phase 1 clinical trial evaluating aflibercept injections for corneal neovascularization has been terminated (NCT01868360).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Balamurali Ambati | Conditions: Corneal Neovascularization | Phase 1 | Status: TERMINATED